scholarly article | Q13442814 |
P356 | DOI | 10.1007/S12032-011-9867-2 |
P8608 | Fatcat ID | release_bslhot4korcfffyd2ogga7trgy |
P698 | PubMed publication ID | 21360018 |
P2093 | author name string | Cheng Zhiyong | |
Liang Wentong | |||
Pan Ling | |||
Yang Xiaoyang | |||
P2860 | cites work | Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation | Q22004269 |
Regulation of angiogenesis and tumor growth by p110 alpha and AKT1 via VEGF expression | Q23910931 | ||
Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells | Q24300331 | ||
Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN | Q24322051 | ||
P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 | ||
The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis | Q24531835 | ||
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche | Q24600542 | ||
Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. | Q34327110 | ||
PI3K-Akt pathway: its functions and alterations in human cancer | Q34362034 | ||
PTEN controls tumor-induced angiogenesis | Q35282160 | ||
PI3K/PTEN signaling in tumorigenesis and angiogenesis | Q36982971 | ||
AKT signaling in regulating angiogenesis | Q37089915 | ||
Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells | Q37116110 | ||
PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells | Q39852386 | ||
PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines | Q39864792 | ||
Identification of adenosine receptor subtypes expressed in the human endothelial-like ECV304 cells | Q40441841 | ||
PTEN and phosphatidylinositol 3'-kinase inhibitors up-regulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment | Q42163038 | ||
Quantification of VEGF isoforms and VEGFR transcripts by qRT-PCR and their significance in acute myeloid leukemia | Q47911803 | ||
PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies | Q57591287 | ||
PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects | Q64379300 | ||
Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome | Q73701961 | ||
Inhibition of vascular endothelial growth factor (VEGF)-165 and semaphorin 3A-mediated cellular invasion and tumor growth by the VEGF signaling inhibitor ZD4190 in human colon cancer cells and xenografts | Q80159172 | ||
A reappraisal by quantitative flow cytometry analysis of PTEN expression in acute leukemia | Q80568689 | ||
P433 | issue | 2 | |
P921 | main subject | leukemia | Q29496 |
P304 | page(s) | 1084-1092 | |
P577 | publication date | 2011-03-01 | |
P1433 | published in | Medical Oncology | Q2152666 |
P1476 | title | PTEN's regulation of VEGF and VEGFR1 expression and its clinical significance in myeloid leukemia | |
P478 | volume | 29 |
Q28384798 | Antisense oligonucleotides against microRNA-21 reduced the proliferation and migration of human colon carcinoma cells |
Q43138991 | Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21. |
Q37137760 | Loss of Pten promotes angiogenesis and enhanced vegfaa expression in zebrafish. |
Q42011584 | PI3K/AKT/PTEN Signaling as a Molecular Target in Leukemia Angiogenesis |
Q35585704 | VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy |
Search more.